Key result
Therapeutic lifestyle changes and adjunctive drug therapies reduce the incidence of and mortality from a first myocardial infarction and stroke.
Why the study?
CVD is the leading public health problem in the United States and worldwide, but primary prevention of MI and stroke remains difficult to achieve in practice.
Do therapeutic lifestyle changes and adjunctive drug therapies prevent first myocardial infarction and stroke in the general population?
Design
Review
Authors
Loading...
Supports primary prevention strategies; leaves open optimal combinations and adherence in diverse populations.
Do therapeutic lifestyle changes and adjunctive drug therapies prevent first myocardial infarction and stroke in the general population?
Therapeutic lifestyle changes combined with appropriate adjunctive pharmacotherapy remain the cornerstone for primary prevention of cardiovascular disease.
Caldwell et al. (2018) conducted a review in Cardiovascular disease (myocardial infarction and stroke). Therapeutic lifestyle changes and adjunctive drug therapies was evaluated. Therapeutic lifestyle changes and adjunctive drug therapies reduce the incidence of and mortality from a first myocardial infarction and stroke.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: